SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
---|---|---|---|---|---|---|---|---|
20-Jun-24 8:31 PM View: | Verastem, Inc. (VSTM) | 18-Jun-24 | Grant | 8,333 | -- | -- | 100% 0 to 8.33K | |
15-May-23 4:30 PM View: | Editas Medicine, Inc. (EDIT) | 11-May-23 | Sale | 949 | $9.87 | $9,368.53 | (< 1%) 107.56K to 106.61K | |
06-Mar-23 4:30 PM View: | Editas Medicine, Inc. (EDIT) | 03-Mar-23 | Sale | 184 | $8.89 | $1,635.76 | (< 1%) 107.74K to 107.56K | |
06-Mar-23 4:30 PM View: | Editas Medicine, Inc. (EDIT) | 02-Mar-23 | Grant | 31,500 | -- | -- | 41% 76.24K to 107.74K | |
15-Feb-23 4:30 PM View: | Editas Medicine, Inc. (EDIT) | 13-Feb-23 | Sale | 4,287 | $9.67 | $41,435.10 | (5%) 80.53K to 76.24K | |
12-Jan-23 4:30 PM View: | Editas Medicine, Inc. (EDIT) | 10-Jan-23 | Sale | 1,752 | $8.16 | $14,296.50 | (2%) 82.28K to 80.53K | |
06-Dec-22 4:30 PM View: | Editas Medicine, Inc. (EDIT) | 05-Dec-22 | Sale | 193 | $10.23 | $1,974.39 | (< 1%) 82.47K to 82.28K | |
08-Sep-22 4:30 PM View: | Editas Medicine, Inc. (EDIT) | 06-Sep-22 | Sale | 192 | $15.01 | $2,881.92 | (< 1%) 82.67K to 82.47K | |
06-Jun-22 4:45 PM View: | Editas Medicine, Inc. (EDIT) | 03-Jun-22 | Sale | 1,527 | $11.54 | $17,616.80 | (2%) 84.19K to 82.67K | |
07-Mar-22 4:15 PM View: | Editas Medicine, Inc. (EDIT) | 03-Mar-22 | Sale | 767 | $17.33 | $13,290.30 | (< 1%) 84.96K to 84.19K | |
11-Feb-22 4:20 PM View: | Editas Medicine, Inc. (EDIT) | 10-Feb-22 | Grant | 53,499 | -- | -- | 170% 31.46K to 84.96K | |
13-Jan-22 4:17 PM View: | Editas Medicine, Inc. (EDIT) | 11-Jan-22 | Market Sale | 1,744 | $25.70 | $44,820.80 | (5%) 33.21K to 31.46K | < 1% |
23-Dec-21 4:09 PM View: | Editas Medicine, Inc. (EDIT) | 22-Dec-21 | Grant | 4,471 | -- | -- | 16% 28.73K to 33.21K | |
10-Aug-21 4:33 PM View: | Editas Medicine, Inc. (EDIT) | 09-Aug-21 | Option Exercise | 2,500 | $30.65 | $76,625.00 | 9% 28.73K to 31.23K | |
10-Aug-21 4:33 PM View: | Editas Medicine, Inc. (EDIT) | 09-Aug-21 | Market Option Sale (Planned) | 2,500 | $60.00 | $150,000.00 | (8%) 31.23K to 28.73K | |
30-Jun-21 4:11 PM View: | Editas Medicine, Inc. (EDIT) | 28-Jun-21 | Option Exercise | 2,500 | $30.65 | $76,625.00 | 9% 28.73K to 31.23K | |
30-Jun-21 4:11 PM View: | Editas Medicine, Inc. (EDIT) | 28-Jun-21 | Market Option Sale (Planned) | 2,500 | $50.00 | $125,000.00 | (8%) 31.23K to 28.73K | |
04-Mar-21 4:19 PM View: | Editas Medicine, Inc. (EDIT) | 02-Mar-21 | Grant | 10,303 | -- | -- | 56% 18.43K to 28.73K | |
13-Jan-21 4:11 PM View: | Editas Medicine, Inc. (EDIT) | 12-Jan-21 | Market Sale | 1,568 | $78.27 | $122,727.00 | (8%) 20.0K to 18.43K | 4% |
10-Jan-20 4:05 PM View: | Editas Medicine, Inc. (EDIT) | 09-Jan-20 | Grant | 20,000 | -- | -- | 100% 0 to 20.0K | |
29-Oct-19 8:57 PM View: | Momenta Pharmaceuticals Inc. (MNTA) | 25-Oct-19 | Private Sale (Planned) | 6,802 | $15.00 | $102,030.00 | (50%) 13.62K to 6.81K | |
21-Oct-19 4:18 PM View: | Momenta Pharmaceuticals Inc. (MNTA) | 18-Oct-19 | Planned Private Option Sale | 2,936 | $13.83 | $40,604.90 | (18%) 16.55K to 13.62K | |
21-Oct-19 4:18 PM View: | Momenta Pharmaceuticals Inc. (MNTA) | 17-Oct-19 | Option Exercise | 9,750 | -- | -- | 143% 6.8K to 16.55K | |
16-Apr-19 5:07 PM View: | Momenta Pharmaceuticals Inc. (MNTA) | 13-Apr-19 | Disposition | 4,725 | -- | -- | (41%) 11.53K to 6.8K | |
19-Feb-19 4:55 PM View: | Momenta Pharmaceuticals Inc. (MNTA) | 14-Feb-19 | Market Sale (Planned) | 703 | $13.10 | $9,209.30 | (6%) 12.23K to 11.53K | (4%) |
14-Feb-19 4:28 PM View: | Momenta Pharmaceuticals Inc. (MNTA) | 13-Feb-19 | Market Option Sale (Planned) | 1,410 | $12.70 | $17,907.00 | (10%) 13.64K to 12.23K | (8%) |
14-Feb-19 4:28 PM View: | Momenta Pharmaceuticals Inc. (MNTA) | 12-Feb-19 | Option Exercise | 4,870 | -- | -- | 56% 8.77K to 13.64K |